Olswang selects dna* ahead of competition

Axxia, a leading supplier of Practice Management Systems (PMS), and creator of dna*, the first Practice and Case management system to be developed on a business process management platform, today announced that law firm Olswang has selected to upgrade to Axxia dna* . The decision launches a 12 month project which sees Olswang roll out Axxia dna* in a series of phases throughout the firm.

As an existing user of Axxia Arista, Olswang took the decision to launch a formal review process. Vendors were invited to demonstrate the suitability of their product to fulfil current requirements and any future plans the firm may have, functional and technical capabilities and the overall business approach and company compatibility to the firm.

“We wanted to ensure that we had fully reviewed all options available to us rather than automatically upgrading to Axxia dna*. Throughout the tender process Axxia met both technical and business requirements”, commented Clive Knott, Olswang IT Director.

“There were a number of reasons that made Axxia dna* our preferred choice; they clearly demonstrated the solution and the likely business, time and financial savings, the increased business efficiencies, the web based browser platform and the underlying business process management”, Knott continued.

Phase one of the project focuses on time, billing and enquiries with phase two moving towards conflict and risk management.

Stuart Holden, Axxia’s managing director, commented “Olswang is a strategic win for Axxia dna* as it clearly demonstrates the strength and positioning of the product against the other PMS solutions available. Throughout the sales process we have been aware of the importance of demonstrating the capabilities and compatibility of the product. We are thrilled that to date we have achieved this and are looking forward to the next 12 months as the project develops.”

Published on: 12-09-2007